Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.

@article{Koeck2012RadiotherapyFE,
  title={Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.},
  author={Julia Koeck and Yasser Abo-Madyan and Frank Lohr and Dr. Florian Stieler and Jan Kriz and R P Mueller and Frederik Wenz and Hans Theodor Eich},
  journal={International journal of radiation oncology, biology, physics},
  year={2012},
  volume={83 1},
  pages={268-76}
}
PURPOSE Cure rates of early Hodgkin lymphoma (HL) are high, and avoidance of late complications and second malignancies have become increasingly important. This comparative treatment planning study analyzes to what extent target volume reduction to involved-node (IN) and intensity-modulated (IM) radiotherapy (RT), compared with involved-field (IF) and three-dimensional (3D) RT, can reduce doses to organs at risk (OAR). METHODS AND MATERIALS Based on 20 computed tomography (CT) datasets of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

A decade of comparative dose planning studies for early-stage Hodgkin lymphoma: what can we learn?

International journal of radiation oncology, biology, physics • 2014
View 6 Excerpts
Highly Influenced

Minimizing Cardiac Risks With Contemporary Radiation Therapy for Hodgkin Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2016

Similar Papers

Loading similar papers…